Clinical Trial

FRAILTY Classification Algorithm for the Corsano CARDIOWATCH 287-2: a Development and Validation Study

Study acronym: FRAILTY-CW2
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The FRAILTY-CARDIOWATCH study is investigating how well the Corsano CardioWatch 287-2, a wrist-worn medical device, can classify frailty in patients. Frailty is a condition often seen in older adults, characterized by decreased strength, endurance, and overall health, which can make individuals more vulnerable to illness or injury. The goal of this study is to develop an algorithm that can accurately assess frailty using the device. In phase 1 of the study, data will be collected from patients aged 70 or older who are scheduled for heart-related procedures, such as valve replacements or pacemaker implantation. The study aims to compare the frailty classifications of the CardioWatch with two established methods: the Geriatric 8 (G8) questionnaire and the FRAIL scale. It will also compare the CardioWatch with the 6-minute walk test. Patients will wear the CardioWatch for six days-three days before their procedure and three days after-and complete the G8, FRAIL, and 6-minute walk tests. The collected data will help develop and train the frailty classification algorithm. The main focus is to evaluate how well the frailty classifications from the CardioWatch match those from the other tests. This research could potentially lead to a more accurate and continuous way to monitor frailty in patients using wearable technology.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-09.
Trial Details
NCT Number NCT06930833
Lead Sponsor Corsano Health B.V.
Conditions Cardiac Arrythmias, Valve Heart Disease, Cardiac Ischemia
Enrollment 20 participants
Start Date 2025-05
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-04-20